6-hydroxy-5-(2-methoxyphenoxy)-1,4-dihydro-[2,2'-bipyrimidin]-4-one, 98%, 10g

(1-Methyl-piperidin-4-yl)-acetic acid, 95.0%, 250mg

(1S,2R,4S,5R)-1-Benzyl-2-(hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride, 99.0%, 5g

Methyl N-Boc-piperidine-3-carboxylate, 95.0%, 100g

Matraz de fondo redondo de dos bocas 2000 ml NS 29/32

(4R,5S,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-ol, 98%, 1g

4-CHLORO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 500mg

5-Chloro-2-(trifluoromethoxy)phenylacetic acid, 1g

2-BENZYL-6-NITRO-1,2,3,4-TETRAHYDRO-ISOQUINOLINE HCL, 97.0%, 1g

2,5-Difluoro-3-nitrobenzoic acid, 95.0%, 5g

5-sec-Butyl-[1,3,4]thiadiazol-2-ylamine, 95.0%, 1g

4-Bromo-2-methyl-2H-pyrazolo[3,4-c]pyridine, 97%, 100mg

(4S,4'S)-2,2'-Methylenebis[4,5-dihydro-4-(phenylmethyl)oxazole], 97%, 10g